Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

Groot, A.F. de; Blok, E.J.; Charehbili, A.; Engels, C.C.; Smit, V.T.H.B.M.; Dekker-Ensink, N.G.; ... ; Kroep, J.R. (2019)

Article / Letter to editor

• Neoadjuvant chemotherapy
• Breast cancer
• Zoledronic acid
• Tumor-infiltrating lymphocytes
• HLA class 1
• Pathological complete response

• All authors: Groot, A.F. de; Blok, E.J.; Charehbili, A.; Engels, C.C.; Smit, V.T.H.B.M.; Dekker-Ensink, N.G.; Putter, H.; Kranenbarg, E.M.K.; Velde, C.J.H. van de; Liefers, G.J.; Nortier, J.W.R.; Kuppen, P.J.K.; Burg, S.H. van der; Kroep, J.R.
• Date: 2019-06-30
• Journal: Breast Cancer Research and Treatment
• Volume: 175
• Issue: 3
• Pages: 605 - 615
• DOI: doi:10.1007/s10549-019-05195-y